Charles J. Casamento - Jul 15, 2021 Form 4 Insider Report for RELMADA THERAPEUTICS, INC. (RLMD)

Role
Director
Signature
/s/ Charles J. Casamento
Stock symbol
RLMD
Transactions as of
Jul 15, 2021
Transactions value $
-$104,088
Form type
4
Date filed
7/16/2021, 05:00 PM
Previous filing
Jun 2, 2021
Next filing
Aug 19, 2021

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction RLMD Common Stock Sale -$66.3K -2.14K -26.73% $31.03 5.85K Jul 15, 2021 Direct F1, F2, F3
transaction RLMD Common Stock Sale -$37.8K -1.16K -19.85% $32.49 4.7K Jul 15, 2021 Direct F1, F2, F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 29, 2020.
F2 The number of securities reported represents an aggregate number of shares sold in multiple open market transactions over a range of sales prices. The price reported represents the weighted average price. The Reporting Person undertakes to provide to the staff of the SEC, the Issuer, or a stockholder of the Issuer, upon request, the number of shares sold by the Reporting Person at each separate price within the range.
F3 Sales prices range from $30.66 to $31.60 per share, inclusive.
F4 Sales prices range from $32.32 to $32.93 per share, inclusive